Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients
Clinical trial NCT02877550 · COMPLETED
Trial details
- NCT number
- NCT02877550
- Sponsor
- Swiss Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-15
- Primary completion
- 2020-04-28
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.